Pediatrics

PCV13 recommended for 6- to 18-year-olds at high risk

(HealthDay)—Pneumococcal conjugate vaccine 13 (PCV13) should be administered to certain children aged 6 through 18 years who are at high risk of invasive pneumococcal disease (IPD), according to a policy statement published ...

Pediatrics

Researchers find ear infections down, thanks to vaccine

Otitis media, more commonly known as ear infection, is the leading cause of pediatric health care visits and the most frequent reason children are prescribed antibiotics or undergo surgery. Researchers from the University ...

Diseases, Conditions, Syndromes

Booster dose of new meningitis vaccine may be beneficial

A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a ...

Diseases, Conditions, Syndromes

Vaccinated children: A powerful protection for older adults

Children who receive a vaccine to prevent blood and ear infections, appear to be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults. Results of a new Vanderbilt ...

page 4 from 6